Hui Huang | Precision Medicine | Best Researcher Award

Hui Huang | Precision Medicine | Best Researcher Award

Prof. Dr. Hui Huang, The Eighth Affiliated Hospital of Sun Yat-Sen University, China

Prof. Hui Huang is Vice President of The Eighth Affiliated Hospital of Sun Yat-sen University and a renowned expert in vascular calcification and chronic disease prevention. 📚 He has authored 100+ high-impact papers in journals like Circulation and J Clin Invest, earning honors like ESI Highly Cited and Top 100 High-Value Papers. 🏆 A recipient of China’s Excellent Young Scientists Fund, he directs multiple prestigious laboratories and holds several international patents. 🔬 His research explores metabolic and immune mechanisms in chronic kidney disease and vascular aging.

Publication Profile

Scopus

Education

Prof. Dr. Hui Huang has authored over 100 peer-reviewed papers in prestigious journals such as Circulation (2022, 2023), J Clin Invest. (2021, 2022, 2025), Hypertension (2018, 2021, 2022), STTT (2022–2024), Kidney Int. (2024), and Cardiovasc Res. (2023) 📚. His impactful work has earned distinctions like ESI Highly Cited Papers, Top 100 High-Value Papers, and journal Cover Stories 🏅. A recipient of China’s National Science Fund for Excellent Young Scholars 🎓, he also led the development of the Expert Consensus on Vascular Calcification, offering vital clinical guidance for practitioners in the field of cardiovascular and renal medicine ❀đŸ©ș.

Experience

Prof. Dr. Hui Huang has led more than 13 major research projects, predominantly funded by the National Natural Science Foundation of China (NSFC) 🔬🇹🇳. His groundbreaking work focuses on unraveling the innovative mechanisms behind arterial calcification, chronic kidney disease, and inflammation đŸ§ đŸ«€. These projects are long-term, high-budget, and scientifically robust, highlighting their critical importance on both national and global stages 🌍💰. Through his pioneering research, Prof. Huang is driving transformative advancements in cardiovascular and renal health, contributing significantly to medical science and improving patient outcomes 🚀đŸ©ș.

Research Focus

Prof. Dr. Hui Huang is a leading researcher in biomedical sciences, with a strong focus on cardiovascular disease, immunology, toxicology, and metabolic disorders. Her work spans areas such as inflammation in the central nervous system, myocardial infarction, diabetes-related metabolomics, and environmental health risks like metal toxicity. đŸŒĄïžđŸ§ đŸ«€ She also explores digital therapeutics and sex-based differences in disease outcomes, making her contributions highly interdisciplinary. đŸ“ŠđŸ’» Her research integrates clinical, molecular, and environmental insights to develop novel strategies for disease prevention and treatment. A strong advocate for translational medicine, Prof. Huang bridges lab science with real-world health challenges.

Publication Top Notes

The Innate Immune Sensor Zbp1 Mediates Central Nervous System Inflammation Induced by Angiostrongylus Cantonensis by Promoting Macrophage Inflammatory Phenotypes

Targeted LC-MS/MS method of oxylipin profiling reveals differentially expressed serum metabolites in type 2 diabetes mice with panaxynol

Ellagic acid-enhanced biocompatibility and bioactivity in multilayer core-shell gold nanoparticles for ameliorating myocardial infarction injury

Sex difference in human diseases: mechanistic insights and clinical implications

Effect of plateletcrit and methylenetetrahydrofolate reductase (MTHFR) C677T genotypes on folic acid efficacy in stroke prevention

Digital therapeutics in hypertension: How to make sustainable lifestyle changes

Associations of essential metals with the risk of aortic arch calcification: a cross-sectional study in a mid-aged and older population of Shenzhen, China

Michael Harrison | Precision Medicine | Best Researcher Award

Michael Harrison | Precision Medicine | Best Researcher Award

Dr. Michael Harrison, UCSF, United States

Dr. Michael Harrison is a pioneering pediatric surgeon and fetal therapy expert. 🎓 He earned his B.A. from Yale (1965) and M.D. from Harvard Medical School (1969), followed by extensive surgical training at Massachusetts General Hospital and fellowships in pediatric surgery. đŸ„ He joined UCSF in 1978, where he became a Full Professor and founded the Fetal Treatment Center. đŸ‘¶ His groundbreaking work in fetal surgery has earned him numerous accolades, including the Golden Plate Award and presidency of the International Fetal Medicine and Surgery Society. 🌍 Now Professor Emeritus at UCSF, he continues to shape the field of pediatric surgery. ✹

Publication Profile

Scopus

Education

Dr. Michael Harrison 🎓 began his academic journey at Yale University (1961-1965), earning a B.A. before pursuing his M.D. in Medicine at Harvard Medical School (1965-1969) đŸ„. He completed his surgical residency at Massachusetts General Hospital (1969-1971) and advanced his expertise as a Postdoctoral Fellow in Allergy & Immunology at the National Institute of Allergy and Infectious Disease (1971-1973) 🧬. Returning to Massachusetts General, he served as a Senior Resident (1973-1974) and Chief Resident (1974-1975) 🔬. Further specializing, he completed fellowships in Pediatric Surgery at Rikshospitalet (1975-1976) 🇳🇮 and Children’s Hospital of Los Angeles (1976-1978) đŸ‘¶đŸ©ș.

Experience

Dr. Michael Harrison đŸ„ has been a Founding Member of the International Fetal Medicine and Surgery Society (1981-present) đŸ‘¶ and has served as its President at the Annual Meeting (1989, 2006) đŸŽ€. He has contributed as a Committee Member for the Medical Advisory Committee of the American Association of Tissue Banks (1993-present) 🧬 and chaired the Committee on Fetal Therapy at APSA (1994-1996) đŸ„. A Board Member of the International Society of the Fetus as Patient (1997-present) 🌍, he also consults for the MOMS study (2003-present) đŸ€°. Since 2010, he has been Vice President of the California Academy of Medicine 📚.

Awards

Dr. Michael Harrison 🏅 has received numerous prestigious honors, including the Golden Plate Award (1982, 1988) 🏆, the William E. Ladd Medal (2010) 🏅, and the Lifetime Achievement Award (2011) 🌟 from the International Fetal Medicine and Surgery Society. He was elected to the Institute of Medicine (2009) 📜 and honored with the Denis Browne Gold Medal (2013) đŸ”ïž. As a celebrated lecturer, he has delivered keynote addresses worldwide 🌍, including at the Nobel Minisymposium on Fetal Medicine (1998) đŸŽ€. His groundbreaking contributions in pediatric surgery have earned him global recognition and lasting influence in the field.

Research Focus

Dr. Michael R. Harrison is a pioneering surgeon and researcher in pediatric surgery and fetal therapy đŸ„đŸ‘¶. His work focuses on maternal-fetal surgery, particularly for conditions like esophageal atresia and diaphragmatic hernia. He has contributed to the development of magnetic compression anastomosis đŸ§Č and other innovative minimally invasive surgical devices 🔬. His research advances the treatment of complex congenital disorders and improves outcomes for newborns. With numerous publications, he has significantly impacted pediatric device clinical trials 📊. Dr. Harrison’s groundbreaking contributions continue to shape the future of pediatric and fetal surgical care đŸšŒâœš.

Publication Top Notes

Pediatric Device Clinical Trials Activity: 1999–2022

Lessons Learned From the First-In-Human Compassionate Use of Connect-EAℱ in Ten Patients With Esophageal Atresia

Evaluation of a Magnetic Compression Anastomosis for Jejunoileal Partial Diversion in Rhesus Macaques

Sonographic Predictors of Survival in Fetal Diaphragmatic Hernia

Beyond the gut: spectrum of magnetic surgery devices

The Rearing of Maternal–Fetal Surgery: The Maturation of a Field from Conception to Adulthood

The novel application of an emerging device for salvage of primary repair in high-risk complex esophageal atresia

Esophageal Magnetic Compression Anastomosis in Esophageal Atresia Repair: A PRISMA-Compliant Systematic Review and Comparison with a Novel Approach

An experimental study on long term outcomes after magnetic esophageal compression anastomosis in piglets

Novel device for endoluminal esophageal atresia repair: First-in-human experience

Dr. Alberto Camacho Morales|Personalized Medicine|Excellence in Researchd

Dr. Alberto Camacho Morales|Personalized Medicine|Excellence in Research

Dr. Alberto Camacho Morales at Abdul wali khan university mardan,Pakistan

PROFILE  

 

Google scholar

Orcid

scopus.

Early Academic Pursuits 🎓

Alberto Camacho Morales’s academic journey is a testament to his dedication to biomedical sciences. After earning a Bachelor’s degree in Biology from the Faculty of Sciences at the National Autonomous University of Mexico (UNAM) in 1999, he pursued advanced studies with unwavering focus. Driven by a passion for understanding cellular processes, he completed a Ph.D. in Biomedical Sciences at the Institute of Cellular Physiology (UNAM) in 2007. His doctoral research laid a strong foundation for his specialization in metabolic and neurophysiological sciences. Alberto’s pursuit of academic excellence culminated in a postdoctoral fellowship at the Institute of Metabolic Science, University of Cambridge, England (2007–2011). These experiences solidified his expertise in metabolic programming, a field where he has become a pioneering voice.

Professional Endeavors 🏱

Since completing his postdoctoral studies, Dr. Camacho Morales has held several influential roles in academia and research. He began his teaching career as a professor-researcher at the School of Medicine, TecnolĂłgico de Monterrey (2011). By 2012, he transitioned to the Faculty of Medicine, Autonomous University of Nuevo LeĂłn (UANL), where he assumed roles that included leading molecular and biochemical studies and coordinating critical academic programs for graduate and undergraduate students.

Dr. Camacho has also extended his expertise beyond academia as a President and Member of Biosecurity and Research Committees at Accelerium Clinical Research, a testament to his ability to bridge research and its practical applications in clinical settings. His 17+ years of professional experience in translational science have equipped him to consult and guide preclinical and clinical research projects effectively.

Contributions and Research Focus 🧠

Dr. Camacho Morales’s research contributions have significantly impacted the understanding of metabolic disorders and neurophysiological programming. His primary areas of research include:

Maternal Neuroinflammation and Behavioral Disorders: Investigating how maternal obesity during pregnancy programs neuroinflammation, contributing to behavioral abnormalities in offspring.
Neuronal Plasticity and Addiction: Understanding the role of neuronal plasticity in hypercaloric food addiction and its implications in obesity development.
Metabolic Programming During Pregnancy: Exploring how prenatal metabolic programming influences metabolic and behavioral outcomes in offspring.
Biomarkers of Metabolic Damage: Identifying blood biomarkers associated with metabolic damage in obese individuals, with and without Type 2 diabetes.
Dr. Camacho’s research combines cutting-edge methodologies in molecular biology, neuroscience, and endocrinology, addressing global challenges like obesity, diabetes, and neuropsychiatric disorders.

Accolades and Recognition 🏆

Dr. Camacho Morales’s exemplary work has earned him numerous awards and recognitions:

National Researcher Level III (2024): A prestigious distinction from Mexico’s National System of Researchers.
First Place in Basic Science Research (2023): UANL acknowledged his groundbreaking work in metabolic programming.
Multiple accolades at state and national levels, including awards in research competitions (e.g., Funsalud Prize for Basic Research in 2018).
Marie Curie Postdoctoral Fellowship: A two-year fellowship at the University of Cambridge, funded by the European Union.
His sustained commitment to scientific excellence is also evident in his editorial roles for esteemed journals like Frontiers in Endocrinology and Molecular Psychiatry.

Impact and Influence 🌍

As a leader in his field, Dr. Camacho Morales has made significant contributions to the academic community. His roles as a professor and mentor at UANL have inspired countless students to pursue careers in biomedical sciences. He coordinates critical courses in molecular biology, biochemistry, and cellular biology for master’s and doctoral programs, shaping future researchers’ perspectives.

His editorial and peer-review roles for high-impact journals, such as Diabetes and Molecular Neuroscience, demonstrate his influence in advancing global biomedical research. By reviewing and editing scientific literature, he has contributed to the integrity and progression of his field.

Legacy and Future Contributions đŸŒ±

Dr. Camacho Morales’s work has lasting implications for understanding and treating metabolic and neurophysiological disorders. His research on the programming of metabolic and behavioral outcomes in offspring provides valuable insights for developing preventive and therapeutic strategies.

 

🎓Publication 

Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice

  • Authors   : Xavier Prieur, Crystal YL Mok, Vidya R Velagapudi, Vanessa NĂșñez, LucĂ­a Fuentes, David Montaner, Ko Ishikawa, Alberto Camacho, Nuria Barbarroja, Stephen O’Rahilly, Jaswinder K Sethi, Joaquin Dopazo, Matej OreĆĄič, Mercedes Ricote, Antonio Vidal-Pui
  • Journal    :American Diabetes Association
  • Year         :2011

Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death

    • Authors   : Alberto Camacho, Lourdes Massieu
    • Journal    : Archives of medical research
    • Year         :2006

Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum

  • Authors   : Erika Rodrı́guez-Martı́nez, Alberto Camacho, Perla D Maldonado, JosĂ© Pedraza-Chaverrı́, Daniel Santamarı́a, Sonia GalvĂĄn-Arzate, Abel Santamarı́a
  • Journal    : Brain research
  • Year         :2000

In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum

  • Authors   :Abel SantamarĂ­a, MarĂ­a E JimĂ©nez-Capdeville, Alberto Camacho, Erika RodrĂ­guez-MartĂ­nez, Abigail Flores, Sonia GalvĂĄn-Arzate
  • Journal     :Neuroreport
  • Year         :2001

Microglia activation due to obesity programs metabolic failure leading to type two diabetes

  • Authors   : R Maldonado-Ruiz, L Montalvo-MartĂ­nez, Lizeth Fuentes-Mera, A Camacho
  • Journal    : Nutrition & diabetes
  • Year         :2017